Grid Exponential

SphereBio develops biotech platforms that deliver molecules to cells, training them to generate specific responses to health issues. The company is now using platforms to offer pharmaceutical and veterinary companies a novel approach to potentiate vaccines and therapeutics tailored to specific diseases, such as cancer. It was founded in 2023.

MicroIN is a biotechnology company that specializes in the development of formulations to enhance cellular bioinputs.

GlycoX focuses on combining nature’s wisdom with cutting-edge technology that transforms the landscape of diabetes management.

Over 90% of drugs fail in clinical trials, largely due to the limited representativeness of pre-clinical models. Traditional models—whether animal or in vitro—fail to effectively capture humans' complexity and genetic diversity. At Invitrall, we are overcoming this challenge. We develop advanced diseases in vitro models that represent human genetic diversity, providing innovative solutions to test the safety and efficacy of pharmaceutical and cosmetic products. Our technology bridges the gap left by traditional experimental models, helping to accelerate the development of therapies for various diseases.

Scitherm is a startup that dedicates to validating treatments for the control of overweight and obesity.

BioBlends develops biopreservatives for the food industry to extend the shelf life of food products.

Polymera leverages the adaptive mechanisms of an extremophile antarctic bacterium to develop naturally biodegradable biopolymers.

Protiva Bioinks is a biotech startup that produces low-cost and eco-friendly dyes for textile industrial production. It offers a wide range of natural colorants derived from microorganisms that are cost-effective, sustainable, and can replace synthetic dyes. Protiva's mission is to transform dyeing in the textile industry, creating a more sustainable future. Its headquarters is located in Comuna 1, Buenos Aires Autonomous City.

MIGMA uses Artificial Intelligence to accelerate the discovery of new synergistic combinations of antioxidants.

Biodiversity Intelligence is a monitoring system that integrates environmental metagenomics, satellite-based monitoring biodiversity.

CyanoMin harnesses cyanobacteria to make carbon-negative minerals without mining, reducing the net carbon footprint of the products.

Apasomics is a biotechnology company pioneering bone-targeted drug delivery to transform the treatment of osteoporosis, and skeletal disorders. Our apasome-based nanocarriers deliver bisphosphonates directly to the bone, ensuring maximum efficacy while minimizing side effects. By combining nanotechnology, precision medicine, and advanced drug delivery, we aim to revolutionize bone health treatments—enhancing therapeutic outcomes, improving patient quality of life, and opening new frontiers in regenerative medicine.

Monte Caldera is a science-driven organization that leverages fundamental Physics to build the solutions for a better world. Its core services are based on a solid scientific approach in parallel to knowledge of manufacturing processes across diverse industries. The company also renders consulting and molecular-level simulation services to a wide array of industries

Bioplastix is revolutionizing the plastics industry by addressing the urgent need for sustainable materials. Bioplastics currently account for only 1% of the global plastics market, highlighting a vast opportunity for growth and innovation. Our proprietary technology leverages genetically modified E. coli to produce advanced copolymers ok PLA, PHB, and other compounds. These bioplastics are derived from renewable sources, offering superior performance at competitive prices. We integrate cutting-edge artificial intelligence to optimize our strains and bioprocesses, enabling unparalleled efficiency and scalability. Our mission is to build the world's most powerful bioplastics formulation and production platform, setting a new standard for sustainable materials.

APEXzymes develops high-performance microbial technologies for the industrial production of biofertilizers and enzymes.

CellRep develops cell reprogramming strategies to increase the functionality of immune cells, improving the efficacy of cell therapies.

We use insects to process organic waste in modular units called bioreactors and offer this technology as a waste management service. This modular infrastructure allows us to integrate our units into the existing waste infrastructure of our clients and, at their facilities, convert their waste into high-value and low-impact protein, fertilizer and, because we have a carbon negative process, carbon bonds.

Over 90% of drugs fail in clinical trials, largely due to the limited representativeness of pre-clinical models. Traditional models—whether animal or in vitro—fail to effectively capture humans' complexity and genetic diversity. At Invitrall, we are overcoming this challenge. We develop advanced diseases in vitro models that represent human genetic diversity, providing innovative solutions to test the safety and efficacy of pharmaceutical and cosmetic products. Our technology bridges the gap left by traditional experimental models, helping to accelerate the development of therapies for various diseases.

Sylvarum is an innovative biotech startup focused on plant electrostimulation technology. The company employs external electric and magnetic fields to enhance the natural metabolic processes of plants. This technology aims to improve germination rates, accelerate growth, and increase ion uptake capacity, ultimately leading to significant yield improvements for agricultural producers. By controlling plant metabolism through electrostimulation, Sylvarum offers a solution for the agricultural sector to enhance crop productivity effectively.

Bioeutectics focuses on creating environmentally friendly industrial products by providing high-performance, natural solvents. Utilizing proprietary eutectic technology, the company produces solvents that mimic the natural processes of plants, using 100% renewable resources. This innovation allows Bioeutectics to replace traditional petrochemical solvents in various industrial applications, promoting sustainability. Their product line caters to diverse sectors, including food, pharmaceuticals, and personal care, and is designed to be non-toxic, biodegradable, and customizable to meet specific industry needs. Through these advancements, Bioeutectics aims to lead the market in offering sustainable alternatives that enhance environmental responsibility in industrial processes.

Dogma BioTech is a biotechnology firm that develops protein-based therapeutics.

At Alkemio, we develop sustainable Molecular Adsorption Technology to efficiently separate and purify rare earth elements (REEs). Based in Buenos Aires, we offer mining companies a selective, cost-effective, and eco-friendly alternative to conventional methods, enhancing REE recovery while reducing waste, energy use, and refining steps.

Nunatak Biotech is an operator of a biotechnology company intended to promote plant growth in adverse conditions and soil restoration.

AlgaLife specializes in disrupting microalgae production processes allowing 95% cheaper cultivation costs with high productive caps.

Ocular Bio Design is a tissue engineering company for the regeneration of visual function.

Restoring crops' ability to defend against pests.

Smart delivery biocapsules that enhance crop production.

Qnity leverages quantum electrochemical principles to develop tools for drug discovery and other product innovations.

Aquit develops preventive treatments for infections in fish that replace antibiotics, improve survival rates, and boost natural immunity.

Gisens Biotech is a biotechnology firm specializing in bioelectronics and nanotechnology. The company is recognized for its innovative approach to problem-solving and employs advanced technology to enhance its offerings. One of its flagship products is the Nano-Lab, a portable diagnostic device designed to measure and control various biomarkers. This device can accurately analyze concentrations of renal biomarkers such as urea, creatinine, and potassium from a single drop of blood, urine, or saliva. By providing real-time measurements through a user-friendly application, the Nano-Lab enables efficient health monitoring, potentially transforming the way biomarker assessments are conducted and interpreted.

Embryoxite creates non-invasive diagnostic services for pre-implantation embryos used in human-assisted reproduction procedures.

EYWA designs the best processes and products to boost the adoption of psychedelic medicine, harnessing the power of biosynthesis.

Corporation - SAU

Ubique Bio is a biotechnology company that has a dedication to make diagnostics available for everyone, everywhere.

We have created a cutting-edge bio-nanotechnology platform that generates various types of nanoparticles with applications in agriculture. Our approach harnesses the power of nanotechnology while also utilizing the distinctive attributes of carefully selected microorganisms.

We are a biotech company Transforming Health through the Microbiome. Future Biome develops next generation prebiotics: Precision fungi-based prebiotics to combat this inflammation with predictable efficacy. The Technology we are developing for this consists of a predictive bioinformatic platform. Our Platform customizes the best fungal prebiotic for each microbiota or market segment, to increase efficacy an effects. We can developed personalized and semi personalized fungal prebiotics. Our First Fungal Prebiotic increased microbiota function up to 500% with 100% efficacy in our in vitro studies against market reference.We are starting clinical trials with these first fungal prebiotic in April 2024

CKapur develops a biological product that specializes in the agricultural sector. It focuses on improving crop nutrition using extremophile microorganisms. It is located in Buenos Aires, Argentina.

At Updairy, we're harnessing the power of microorganisms to create animal-free dairy.

Stämm Biotech is a San Francisco-based company specializing in advanced bioproduction systems designed to address the scaling challenges in the biotech industry. Founded in 2014, Stämm has developed an innovative biomanufacturing solution that integrates microfluidics, electroporation, and robotics, resulting in a compact, all-in-one Bioprocessor. This system has demonstrated productivity levels at least 70 times greater than traditional bioreactors, enabling clients to miniaturize bioreactors and optimize conditions more efficiently. Stämm's technology incorporates various sensors to monitor biological, physical, and chemical variations throughout the bioprocess, facilitating a streamlined approach to microbial growth and monoclonal cell line development. By transforming large-scale biotech operations into a more manageable micro-factory network, Stämm aims to unlock significant market potential in the coming years.

Nat4Bio is an agricultural biotechnology company focused on developing naturally-sourced edible coatings to protect fresh produce from spoilage and decay. Utilizing microbial fermentation of selected fungi and bacteria, the company creates cell-free compounds that harness the active principles of these microbes without using the organisms themselves. Their first product is a natural coating for fresh lemons, designed to replace traditional waxes and chemical fungicides. The coating is formulated from a proprietary blend of glucose-based biopolymers and natural antimicrobials, which help guard against microbial pathogens, oxidation, and dehydration. In addition to lemons, Nat4Bio is prototyping similar formulations for blueberries and avocados, with plans to expand its product offerings to cover a wide range of fruit types. By providing a safer and more sustainable alternative to synthetic pesticides and waxes, Nat4Bio aims to enhance the safety, quality, and availability of fresh fruit while reducing food waste.

New Organs develops genetically modified pigs to satisfy unmet organ demand through xenotransplantation.

Kresko RNAtech is a biotechnology company focused on the development and production of nutraceuticals. The company specializes in identifying bioactive ribonucleic acid (RNA) from natural sources, utilizing advanced techniques such as machine learning and bioinformatics. By uncovering RNAs that may offer health benefits, Kresko RNAtech aims to enhance human well-being and help individuals manage stressful and changing conditions through innovative RNA technologies.

Syocin Biotech is developing a synthetic biology platform for the redesign of natural existing biomolecules to precisely target plant bacterial pathogens that threaten world food availability.

OncoPrecision is a company that focuses on improving cancer therapy outcomes by utilizing a patient micro avatar platform. This innovative platform employs single-cell high-throughput biology and machine learning to generate comprehensive patient-derived phenotypic biomarkers. By doing so, it enables oncologists to make informed, data-driven decisions regarding the selection of cancer therapies tailored to individual patients. The approach aims to increase the success rates of cancer treatments by ensuring that the right therapy is matched to the right patient, thus enhancing overall patient care and treatment effectiveness.

Tomorrow Foods is a company based in Pergamino, Argentina, specializing in the development and production of plant-based ingredients and additives for the food industry. Their offerings cater to various sectors, including sports nutrition, meat extenders, pasta, dressings, soups, sauces, snacks, cereals, functional beverages, dairy substitutes, and bakery products. Tomorrow Foods focuses on providing integrated solutions that allow clients to launch healthy and sustainable products efficiently. By introducing innovative alternatives derived from vegetable proteins, the company aims to promote a diverse and more sustainable diet for consumers.

Microgenesis is a biotechnology company focused on improving fertility and pregnancy health through innovative diagnostic and treatment solutions. It offers a non-invasive fertility test that identifies subclinical inflammation affecting ovarian function and implantation, particularly beneficial for women who have experienced multiple IVF failures. The company's personalized nutritional supplementation aims to restore fertility potential in women, utilizing all-natural and drug-free methods. Operating out of a CLIA-certified lab in Oakland, Microgenesis is expanding its services to obstetricians and gynecologists, as well as direct-to-consumer markets. In addition to its fertility test, the company provides tools to analyze microbiota imbalances linked to infertility and immunological issues, thus addressing complex reproductive health cases comprehensively.

Beeflow S.A., founded in 2016 and based in Buenos Aires, Argentina, specializes in providing professional pollination services to farmers. The company leverages scientific knowledge and technology to enhance bee populations, developing organic compounds that improve the immune systems of bees and guide them to pollinate specific crops. This approach not only helps increase crop yields—reported to be between 20-90% for various fruits such as blueberries, almonds, raspberries, and kiwifruit—but also addresses the decline in bee populations. By focusing on the health and efficiency of bees, Beeflow aims to maintain the security of plant ecosystems and support sustainable agriculture practices.

Microgenesis is a biotechnology company focused on improving fertility and pregnancy health through innovative diagnostic and treatment solutions. It offers a non-invasive fertility test that identifies subclinical inflammation affecting ovarian function and implantation, particularly beneficial for women who have experienced multiple IVF failures. The company's personalized nutritional supplementation aims to restore fertility potential in women, utilizing all-natural and drug-free methods. Operating out of a CLIA-certified lab in Oakland, Microgenesis is expanding its services to obstetricians and gynecologists, as well as direct-to-consumer markets. In addition to its fertility test, the company provides tools to analyze microbiota imbalances linked to infertility and immunological issues, thus addressing complex reproductive health cases comprehensively.

Nanogrow Biotech is a manufacturer of nano antibiotics with the goal of developing novel applications in the pharmaceutical industry, particularly for the treatment of skin diseases.

Cryosmetics is dedicated to advancing the future of cosmetics through the development of natural skincare products. The company focuses on enhancing the diversity of the skin microbiome, utilizing a blend of technology, science, and biology in its approach. By employing natural raw materials and ensuring that its products are free from preservatives and synthetic chemicals, Cryosmetics aims to improve the overall well-being of its customers.

OncoPrecision is a company that focuses on improving cancer therapy outcomes by utilizing a patient micro avatar platform. This innovative platform employs single-cell high-throughput biology and machine learning to generate comprehensive patient-derived phenotypic biomarkers. By doing so, it enables oncologists to make informed, data-driven decisions regarding the selection of cancer therapies tailored to individual patients. The approach aims to increase the success rates of cancer treatments by ensuring that the right therapy is matched to the right patient, thus enhancing overall patient care and treatment effectiveness.

Gisens Biotech is a biotechnology firm specializing in bioelectronics and nanotechnology. The company is recognized for its innovative approach to problem-solving and employs advanced technology to enhance its offerings. One of its flagship products is the Nano-Lab, a portable diagnostic device designed to measure and control various biomarkers. This device can accurately analyze concentrations of renal biomarkers such as urea, creatinine, and potassium from a single drop of blood, urine, or saliva. By providing real-time measurements through a user-friendly application, the Nano-Lab enables efficient health monitoring, potentially transforming the way biomarker assessments are conducted and interpreted.

CASPR Biotech, founded in 2018 and located in San Francisco, California, specializes in the development of a CRISPR-based platform for diagnosing antimicrobial resistances (AMR) and infectious diseases. The company creates portable diagnostic kits that enable the detection of specific DNA and RNA sequences, as well as signature amino acid sequences associated with infectious diseases and genetic mutations. These kits aim to provide healthcare professionals with a simple, rapid, and cost-effective solution for molecular detection, enhancing the accuracy and efficiency of clinical diagnostics.

BioPlaster Research seeks the development of science and technology for the care of the environment and the proliferation of nanotechnology.

Fecundis is a company based in Rosario, Argentina, focused on advancing reproductive biology. It develops innovative solutions aimed at improving sperm competence and enhancing the success rates of assisted reproductive technologies. By utilizing precise technology grounded in scientific research, Fecundis enhances sperm functionality, leading to the generation of more viable embryos. The company’s tools are designed to optimize fertility treatments, ultimately enabling patients to achieve successful pregnancies.

Michroma Corporation is a biotechnology company that specializes in producing natural thermostable colorants derived from filamentous fungi through a fermentation process. Founded in 2019 and based in both San Francisco, California, and Rosario, Argentina, Michroma aims to replace synthetic pigments and those sourced from animals and plants with sustainable, naturally produced alternatives. The company harnesses synthetic biology to develop proprietary fungal strains that generate high-performance ingredients in bioreactors. Currently, Michroma is prototyping its innovative pH-stable and heat-stable food colorants in collaboration with leading food and beverage and cosmetic companies. Additionally, the company is exploring the production of mycoprotein and other ingredients, making strides in the sustainable ingredients market.

Hiamet is biotechnology-based solutions for specific problems related to bioenergy and environmental impact. Hiamet design of processes and additives for the conversion of organic waste into energy.

Syocin Biotech is developing a synthetic biology platform for the redesign of natural existing biomolecules to precisely target plant bacterial pathogens that threaten world food availability.

Microgenesis is a biotechnology company focused on improving fertility and pregnancy health through innovative diagnostic and treatment solutions. It offers a non-invasive fertility test that identifies subclinical inflammation affecting ovarian function and implantation, particularly beneficial for women who have experienced multiple IVF failures. The company's personalized nutritional supplementation aims to restore fertility potential in women, utilizing all-natural and drug-free methods. Operating out of a CLIA-certified lab in Oakland, Microgenesis is expanding its services to obstetricians and gynecologists, as well as direct-to-consumer markets. In addition to its fertility test, the company provides tools to analyze microbiota imbalances linked to infertility and immunological issues, thus addressing complex reproductive health cases comprehensively.

Einsted is a biotechnology company located in Argentina that focuses on the development of innovative electrochemical technology aimed at enhancing bioindustrial processes. The company's flagship product, the BioElectroProcessor, utilizes electrical pulses to induce NanoPulsed Reactions (NPR), which facilitate the production of new starches and optimize their manufacturing. By replacing traditional chemical reactions with this advanced technology, Einsted seeks to promote healthier and more environmentally friendly practices in the Food, Pharma, and Cosmetic industries.

Tomorrow Foods is a company based in Pergamino, Argentina, specializing in the development and production of plant-based ingredients and additives for the food industry. Their offerings cater to various sectors, including sports nutrition, meat extenders, pasta, dressings, soups, sauces, snacks, cereals, functional beverages, dairy substitutes, and bakery products. Tomorrow Foods focuses on providing integrated solutions that allow clients to launch healthy and sustainable products efficiently. By introducing innovative alternatives derived from vegetable proteins, the company aims to promote a diverse and more sustainable diet for consumers.

Stämm Biotech is a San Francisco-based company specializing in advanced bioproduction systems designed to address the scaling challenges in the biotech industry. Founded in 2014, Stämm has developed an innovative biomanufacturing solution that integrates microfluidics, electroporation, and robotics, resulting in a compact, all-in-one Bioprocessor. This system has demonstrated productivity levels at least 70 times greater than traditional bioreactors, enabling clients to miniaturize bioreactors and optimize conditions more efficiently. Stämm's technology incorporates various sensors to monitor biological, physical, and chemical variations throughout the bioprocess, facilitating a streamlined approach to microbial growth and monoclonal cell line development. By transforming large-scale biotech operations into a more manageable micro-factory network, Stämm aims to unlock significant market potential in the coming years.

Radial Biomateriales is a provider of biodegradable packaging and packaging parts. It uses agro-industrial waste to form a packaging solution for biodegradable packaging and industrial or interior design products. The company was founded in 2018 and is based in Zapopan, Mexico.

Enteria is a biotechnology research company that focuses on microbiota analysis services, specifically tailored for women's health. The company operates on a business-to-business model, providing intestinal microbiota analysis as a diagnostic tool for healthcare professionals. Enteria collaborates with research centers and offers customized services for private companies, enhancing the capabilities of healthcare providers in diagnosing and treating patients. Through its innovative approach, Enteria aims to empower healthcare professionals with advanced resources, ultimately improving patient care outcomes.

Zev Biotech is a biotechnology company based in Argentina that specializes in the study of DNA for clinical diagnostics. The company has developed a novel platform for molecular diagnostics, allowing for the creation of customized diagnostic kits tailored to hereditary and infectious diseases, as well as pharmacogenomics. By employing proprietary technologies that integrate reagents, equipment, and software based on microarray techniques, Zev Biotech aims to enhance the accuracy of diagnosing genetic and infectious diseases, surpassing the capabilities of traditional clinical diagnostic methods.

MZP Tech is a company focused on point-of-care coagulation analysis, aiming to improve healthcare delivery through innovative diagnostic methodologies. They develop medical devices capable of rapidly analyzing blood samples, utilizing a disposable micro-machined chip and a portable embedded sensing system. This technology allows for the analysis of a single drop of blood within minutes, measuring blood viscosity. By doing so, MZP Tech enables healthcare professionals to conduct early-stage screenings for various conditions, including cardiovascular diseases, blood-clotting disorders, and hyperviscosity-related issues. Their advancements in hemostasis contribute to better management of bleeding and thrombotic risks, enhancing patient care.

Feedvax is an Argentine company founded in 2018 that specializes in developing oral vaccines for farmed fish, aiming to enhance animal production sustainably. The company has created a platform that delivers in-feed vaccines, beginning with a product targeting streptococcosis in tilapia, a widely farmed fish species. Feedvax's innovative approach allows for easy administration of vaccines through feed, providing an effective and environmentally safe alternative to antibiotics. This method not only protects fish from disease but also minimizes stress and potential contamination, offering a practical solution for fish producers seeking greater efficiency in aquaculture.

Cell Farm is a LATAM's first clean meat startup developing & standardizing a biotechnology process to produce meat from animal stem cells. Cell Farm is a key player in helping Humanity achieve a sustainable future by transforming the food system.

AlgaeBio+ is a company based in Argentina that specializes in the production of natural astaxanthin, an antioxidant derived from the microalga Haematococcus pluvialis. This product is known for its immunoregulatory, anti-inflammatory, and photo-protective properties, making it beneficial in the treatment of various health conditions, including chronic diseases and cancer. AlgaeBio+ serves multiple industries, including pharmaceuticals, nutraceuticals, functional foods, and cosmetics, offering a natural alternative to artificial pigments. The cultivation process begins in laboratory conditions and progresses through production in photobioreactors, ensuring high-quality output. By emphasizing the health benefits of astaxanthin for joints, muscles, vision, and heart health, AlgaeBio+ aims to enhance patient treatment options while promoting preventive care and anti-aging solutions.

Alytix Biotech is a company based in Santa Fe, Argentina, that specializes in developing antibiotic alternatives using bacteriophage technology. The firm aims to address bacterial infections in both human and animal health by offering innovative solutions that include screening, identification, characterization, formulation, and validation of antibiotic resistance. Alytix's focus on improving livestock health helps to reduce unnecessary antibiotic use and enhances environmental sustainability, while also enabling pharmaceutical companies to explore new methods for combating bacterial infections.

Beeflow S.A., founded in 2016 and based in Buenos Aires, Argentina, specializes in providing professional pollination services to farmers. The company leverages scientific knowledge and technology to enhance bee populations, developing organic compounds that improve the immune systems of bees and guide them to pollinate specific crops. This approach not only helps increase crop yields—reported to be between 20-90% for various fruits such as blueberries, almonds, raspberries, and kiwifruit—but also addresses the decline in bee populations. By focusing on the health and efficiency of bees, Beeflow aims to maintain the security of plant ecosystems and support sustainable agriculture practices.

Stämm Biotech is a San Francisco-based company specializing in advanced bioproduction systems designed to address the scaling challenges in the biotech industry. Founded in 2014, Stämm has developed an innovative biomanufacturing solution that integrates microfluidics, electroporation, and robotics, resulting in a compact, all-in-one Bioprocessor. This system has demonstrated productivity levels at least 70 times greater than traditional bioreactors, enabling clients to miniaturize bioreactors and optimize conditions more efficiently. Stämm's technology incorporates various sensors to monitor biological, physical, and chemical variations throughout the bioprocess, facilitating a streamlined approach to microbial growth and monoclonal cell line development. By transforming large-scale biotech operations into a more manageable micro-factory network, Stämm aims to unlock significant market potential in the coming years.

BioPlaster Research seeks the development of science and technology for the care of the environment and the proliferation of nanotechnology.